GFM
JAZZ icon

GF Fund Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

GF Fund Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$258K Buy
1,364
+170
+14% +$29.7K ﹤0.01% 266
2025
Q4 		$203K Sell
1,194
-111
-9% -$17K ﹤0.01% 291
2025
Q3 		$172K Sell
1,305
-243
-16% -$29.1K ﹤0.01% 304
2025
Q2 		$164K Hold
1,548
– – ﹤0.01% 335
2025
Q1 		$192K Buy
1,548
+279
+22% +$36.4K ﹤0.01% 318
2024
Q4 		$156K Buy
+1,269
New +$150K ﹤0.01% 303

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

GF Fund Management's JAZZ Position: Q1 2026 in Review

GF Fund Management increased its Jazz Pharmaceuticals (JAZZ) stake by 14% in Q1 2026, buying an estimated $29.7K and bringing the position to 1,364 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #266.

GF Fund Management first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • GF Fund Management held 1,364 shares of Jazz Pharmaceuticals worth $258K as of Q1 2026.
  • GF Fund Management bought 170 Jazz Pharmaceuticals shares in Q1 2026, an estimated $29.7K.
  • Jazz Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #266 holding.
  • GF Fund Management first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.